Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

By Karjalainen Pasi   Ylitalo Antti   Niemela Matti   Kervinen Kari   Makikallio Timo   Pietila Mikko   Sia Jussi   Tuomainen Petri   Nyman Kai   Airaksinen K. E. Juhani  

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 599-607

Informa Healthcare

Access to resources Recommend Favorite

Clinical safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents in patients with coronary artery disease

By Zhang Feng   Dong Lili   Qian Juying   Ge Junbo  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 75-79

Informa Healthcare

Access to resources Recommend Favorite

Long‐term safety and efficacy of second‐generation everolimus‐eluting stents compared to other limus‐eluting stents and bare metal stents in patients with acute coronary syndrome

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1053-1060

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gender disparity in the use of drug‐eluting stents during percutaneous coronary intervention for acute myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 221-228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of 5‐year outcomes of paclitaxel‐eluting and endeavor zotarolimus‐eluting stents in New York

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 91, Iss. 1, 2018-01 ,pp. : 9-16

John Wiley & Sons Inc

Access to resources Recommend Favorite